Dialysis-treated end-stage kidney disease in Libya: Epidemiology and risk factors

Fathea Abobker Goleg, Norella Chiew Tong Kong, Ramesh Sahathevan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: End-stage kidney disease (ESKD) is now a worldwide pandemic. In concert with this, ESKD in Libya has also increased exponentially in recent decades. This review aims to define the magnitude of and risks for this ESKD epidemic among Libyans as there is a dearth of published data on this subject. Methods: A systematic review was conducted by searching PubMed, EMBASE and Google scholar databases to identify all relevant papers published in English from 2003 to 2012, using the following keywords: end stage, terminal, chronic, renal, kidney, risk factors, Arab, North Africa and Libya. Results: In 2003, the reported incidence of ESKD and prevalence of dialysis-treated ESKD in Libya were the same at 200 per million population (pmp). In 2007, the prevalence of dialysis-treated ESKD was 350 pmp, but the true incidence of ESKD was not available. The most recent published WHO data in 2012 showed the incidence of dialysis-treated ESKD had risen to 282 pmp and the prevalence of dialysis-treated ESKD had reached 624 pmp. The leading causes of ESKD were diabetic kidney disease (26.5 %), chronic glomerulonephritis (21.1 %), hypertensive nephropathy (14.6 %) and congenital/hereditary disease (12.3 %). The total number of dialysis centers was 40 with 61 nephrologists. Nephrologist/internist to patient ratio was 1:40, and nurse to patient ratio was 1:3.7. Only 135 living-related kidney transplants had been performed between 2004 and 2007. There were no published data on most macroeconomic and renal service factors. Conclusions: ESKD is a major public health problem in Libya with diabetic kidney disease and chronic glomerulonephritis being the leading causes. The most frequent co-morbidities were hypertension, obesity and the metabolic syndrome. In addition to provision of RRT, preventive strategies are also urgently needed for a holistic integrated renal care system.

Original languageEnglish
Pages (from-to)1581-1587
Number of pages7
JournalInternational Urology and Nephrology
Volume46
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint

Libya
Chronic Kidney Failure
Dialysis
Epidemiology
Kidney
Diabetic Nephropathies
Glomerulonephritis
Population
Incidence
Northern Africa
Inborn Genetic Diseases
Pandemics
PubMed

Keywords

  • Dialysis-treated end-stage kidney disease
  • Incidence
  • Prevalence
  • Risk factors

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Dialysis-treated end-stage kidney disease in Libya : Epidemiology and risk factors. / Goleg, Fathea Abobker; Kong, Norella Chiew Tong; Sahathevan, Ramesh.

In: International Urology and Nephrology, Vol. 46, No. 8, 2014, p. 1581-1587.

Research output: Contribution to journalArticle

Goleg, Fathea Abobker ; Kong, Norella Chiew Tong ; Sahathevan, Ramesh. / Dialysis-treated end-stage kidney disease in Libya : Epidemiology and risk factors. In: International Urology and Nephrology. 2014 ; Vol. 46, No. 8. pp. 1581-1587.
@article{bd1e755ae77e48c3bfc0b8d70431e16c,
title = "Dialysis-treated end-stage kidney disease in Libya: Epidemiology and risk factors",
abstract = "Purpose: End-stage kidney disease (ESKD) is now a worldwide pandemic. In concert with this, ESKD in Libya has also increased exponentially in recent decades. This review aims to define the magnitude of and risks for this ESKD epidemic among Libyans as there is a dearth of published data on this subject. Methods: A systematic review was conducted by searching PubMed, EMBASE and Google scholar databases to identify all relevant papers published in English from 2003 to 2012, using the following keywords: end stage, terminal, chronic, renal, kidney, risk factors, Arab, North Africa and Libya. Results: In 2003, the reported incidence of ESKD and prevalence of dialysis-treated ESKD in Libya were the same at 200 per million population (pmp). In 2007, the prevalence of dialysis-treated ESKD was 350 pmp, but the true incidence of ESKD was not available. The most recent published WHO data in 2012 showed the incidence of dialysis-treated ESKD had risen to 282 pmp and the prevalence of dialysis-treated ESKD had reached 624 pmp. The leading causes of ESKD were diabetic kidney disease (26.5 {\%}), chronic glomerulonephritis (21.1 {\%}), hypertensive nephropathy (14.6 {\%}) and congenital/hereditary disease (12.3 {\%}). The total number of dialysis centers was 40 with 61 nephrologists. Nephrologist/internist to patient ratio was 1:40, and nurse to patient ratio was 1:3.7. Only 135 living-related kidney transplants had been performed between 2004 and 2007. There were no published data on most macroeconomic and renal service factors. Conclusions: ESKD is a major public health problem in Libya with diabetic kidney disease and chronic glomerulonephritis being the leading causes. The most frequent co-morbidities were hypertension, obesity and the metabolic syndrome. In addition to provision of RRT, preventive strategies are also urgently needed for a holistic integrated renal care system.",
keywords = "Dialysis-treated end-stage kidney disease, Incidence, Prevalence, Risk factors",
author = "Goleg, {Fathea Abobker} and Kong, {Norella Chiew Tong} and Ramesh Sahathevan",
year = "2014",
doi = "10.1007/s11255-014-0694-1",
language = "English",
volume = "46",
pages = "1581--1587",
journal = "International Urology and Nephrology",
issn = "0301-1623",
publisher = "Springer Netherlands",
number = "8",

}

TY - JOUR

T1 - Dialysis-treated end-stage kidney disease in Libya

T2 - Epidemiology and risk factors

AU - Goleg, Fathea Abobker

AU - Kong, Norella Chiew Tong

AU - Sahathevan, Ramesh

PY - 2014

Y1 - 2014

N2 - Purpose: End-stage kidney disease (ESKD) is now a worldwide pandemic. In concert with this, ESKD in Libya has also increased exponentially in recent decades. This review aims to define the magnitude of and risks for this ESKD epidemic among Libyans as there is a dearth of published data on this subject. Methods: A systematic review was conducted by searching PubMed, EMBASE and Google scholar databases to identify all relevant papers published in English from 2003 to 2012, using the following keywords: end stage, terminal, chronic, renal, kidney, risk factors, Arab, North Africa and Libya. Results: In 2003, the reported incidence of ESKD and prevalence of dialysis-treated ESKD in Libya were the same at 200 per million population (pmp). In 2007, the prevalence of dialysis-treated ESKD was 350 pmp, but the true incidence of ESKD was not available. The most recent published WHO data in 2012 showed the incidence of dialysis-treated ESKD had risen to 282 pmp and the prevalence of dialysis-treated ESKD had reached 624 pmp. The leading causes of ESKD were diabetic kidney disease (26.5 %), chronic glomerulonephritis (21.1 %), hypertensive nephropathy (14.6 %) and congenital/hereditary disease (12.3 %). The total number of dialysis centers was 40 with 61 nephrologists. Nephrologist/internist to patient ratio was 1:40, and nurse to patient ratio was 1:3.7. Only 135 living-related kidney transplants had been performed between 2004 and 2007. There were no published data on most macroeconomic and renal service factors. Conclusions: ESKD is a major public health problem in Libya with diabetic kidney disease and chronic glomerulonephritis being the leading causes. The most frequent co-morbidities were hypertension, obesity and the metabolic syndrome. In addition to provision of RRT, preventive strategies are also urgently needed for a holistic integrated renal care system.

AB - Purpose: End-stage kidney disease (ESKD) is now a worldwide pandemic. In concert with this, ESKD in Libya has also increased exponentially in recent decades. This review aims to define the magnitude of and risks for this ESKD epidemic among Libyans as there is a dearth of published data on this subject. Methods: A systematic review was conducted by searching PubMed, EMBASE and Google scholar databases to identify all relevant papers published in English from 2003 to 2012, using the following keywords: end stage, terminal, chronic, renal, kidney, risk factors, Arab, North Africa and Libya. Results: In 2003, the reported incidence of ESKD and prevalence of dialysis-treated ESKD in Libya were the same at 200 per million population (pmp). In 2007, the prevalence of dialysis-treated ESKD was 350 pmp, but the true incidence of ESKD was not available. The most recent published WHO data in 2012 showed the incidence of dialysis-treated ESKD had risen to 282 pmp and the prevalence of dialysis-treated ESKD had reached 624 pmp. The leading causes of ESKD were diabetic kidney disease (26.5 %), chronic glomerulonephritis (21.1 %), hypertensive nephropathy (14.6 %) and congenital/hereditary disease (12.3 %). The total number of dialysis centers was 40 with 61 nephrologists. Nephrologist/internist to patient ratio was 1:40, and nurse to patient ratio was 1:3.7. Only 135 living-related kidney transplants had been performed between 2004 and 2007. There were no published data on most macroeconomic and renal service factors. Conclusions: ESKD is a major public health problem in Libya with diabetic kidney disease and chronic glomerulonephritis being the leading causes. The most frequent co-morbidities were hypertension, obesity and the metabolic syndrome. In addition to provision of RRT, preventive strategies are also urgently needed for a holistic integrated renal care system.

KW - Dialysis-treated end-stage kidney disease

KW - Incidence

KW - Prevalence

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=84906936485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906936485&partnerID=8YFLogxK

U2 - 10.1007/s11255-014-0694-1

DO - 10.1007/s11255-014-0694-1

M3 - Article

C2 - 24671275

AN - SCOPUS:84906936485

VL - 46

SP - 1581

EP - 1587

JO - International Urology and Nephrology

JF - International Urology and Nephrology

SN - 0301-1623

IS - 8

ER -